Search the GHTC website

Global health R&D delivers for Texas

US government investment in global health R&D has delivered

$201.6 million
to Texas research institutions
3,100+ new jobs
for Texas
Global health R&D at work in Texas

University of Texas Medical Branch at Galveston is using a computer-based discovery approach to identify potential new drugs for dengue and similar diseases for which there are currently no effective treatments. Almost half of the world’s population is at risk for dengue, a mosquito-borne infection related to hepatitis C, West Nile, and yellow fever. New treatments could have a huge impact on improving health worldwide.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: PATH/Cornelius Brudi